Results 21 to 30 of about 880,202 (263)

Liver transplantation for primary and metastatic liver cancers [PDF]

open access: yesTransplant International, 2008
Liver transplantation for hepatic malignancies has emerged as a well-documented and proven treatment modality. However, early unsatisfactory results emphasized that only a highly selected patient population would benefit from transplantation. Currently, 15% of all liver transplants performed are for hepatocellular carcinoma (HCC).
Emir, Hoti, Rene, Adam
openaire   +2 more sources

Primary Squamous Cell Carcinoma of the Liver: Case Report and Review of Literature

open access: yesCase Reports in Oncology, 2022
Primary squamous cell carcinoma (SCC) of the liver is a rare cancer type. The overall survival of this cancer is short despite treatment and prognosis are poor.
Omar Fakhreddine   +5 more
doaj   +1 more source

Oral contraceptives and primary liver cancer [PDF]

open access: yesBritish Journal of Cancer, 1989
The relative risk for developing primary liver cancer in northern Italian users of oral contraceptives compared to matched controls was calculated based on reported cases in hospitals in the greater Milan area from 1984-1987. The incidence of and mortality from primary liver cancer as well as the prevalence of oral contraceptive usage have both been ...
C. La Vecchia, E. Negri, F. Parazzini
openaire   +2 more sources

Association of the presence of allergic disease with subsequent risk of liver cancer in a nationwide retrospective cohort among Koreans

open access: yesScientific Reports, 2022
A number of studies have proposed an inverse association between allergic diseases and risk of cancer, but only a few studies have specifically investigated the risk of primary liver cancer, including hepatocellular carcinoma (HCC) and intrahepatic ...
Ji Ah Kim   +8 more
doaj   +1 more source

The safety concerns regarding immune checkpoint inhibitors in liver cancer patients rising mainly from CHB

open access: yesFrontiers in Pharmacology, 2023
Aim: To analyze the safety of immune checkpoint inhibitors in primary liver cancer patients and to identify the risk factors for immune-related adverse events (irAEs).Methods: The study enrolled 106 patients with primary liver cancer, including 81 with ...
Shike Lou   +11 more
doaj   +1 more source

Proteo-genomic characterization of virus-associated liver cancers reveals potential subtypes and therapeutic targets

open access: yesNature Communications, 2022
The molecular heterogeneity of primary liver cancer remains to be characterised. Here, the authors perform multi-omics analysis of 259 primary liver cancer tissues and identify three distinct molecular subtypes.
Masashi Fujita   +19 more
doaj   +1 more source

Interpretation on the Updated Points of Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition)

open access: yesXiehe Yixue Zazhi, 2022
Since the publication of the Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2019 Edition), many new high-level evidence in line with evidence-based medicine has emerged in the diagnosis and treatment of liver cancer at home and ...
JIN Bao   +3 more
doaj   +1 more source

Hepatocellular Carcinoma: Hope and Challenges [PDF]

open access: yesLiaquat National Journal of Cancer Care, 2021
Cancer of the liver and intrahepatic bile ducts is the sixth commonest cancer in the world, with approximately 841,000 new cases reported in 2018.
Misbah Tahir
doaj   +1 more source

Regulatory Mechanism of PD-L1 Expression in Primary Liver Cancer

open access: yesZhongliu Fangzhi Yanjiu, 2021
The application of immunotherapy has become a hot spot in tumor research currently. In particular, immune checkpoint inhibitors have played an important role in the treatment of advanced unresectable primary liver cancer.
LI Shenghao, SHI Xinli
doaj   +1 more source

Primary liver cancers in Japan [PDF]

open access: yesCancer, 1980
Statistical analyses have been made by the Liver Cancer Study Group of Japan of 4031 cases of primary liver cancers diagnosed at 155 institutes during the period of Jan. 1, 1968-Dec. 31, 1977, based on the questionnaire in the form of individual file. They comprised 2411 cases of hepatocellular carcinoma, 268 of cholangiocellular carcinoma, 58 of the ...
openaire   +2 more sources

Home - About - Disclaimer - Privacy